KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Times Interest Earned (2023 - 2025)

Historic Times Interest Earned for Travere Therapeutics (TVTX) over the last 9 years, with Q3 2025 value amounting to $8.9.

  • Travere Therapeutics' Times Interest Earned rose 14440.15% to $8.9 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.03, marking a year-over-year increase of 7477.74%. This contributed to the annual value of -$28.91 for FY2024, which is 1557.09% up from last year.
  • Per Travere Therapeutics' latest filing, its Times Interest Earned stood at $8.9 for Q3 2025, which was up 14440.15% from -$4.44 recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Times Interest Earned peaked at $8.9 during Q3 2025, and registered a low of -$49.73 during Q1 2024.
  • Its 3-year average for Times Interest Earned is -$22.87, with a median of -$22.94 in 2024.
  • Its Times Interest Earned has fluctuated over the past 5 years, first surged by 3386.91% in 2024, then surged by 14440.15% in 2025.
  • Quarter analysis of 3 years shows Travere Therapeutics' Times Interest Earned stood at -$33.4 in 2023, then surged by 35.06% to -$21.69 in 2024, then surged by 141.05% to $8.9 in 2025.
  • Its Times Interest Earned stands at $8.9 for Q3 2025, versus -$4.44 for Q2 2025 and -$14.72 for Q1 2025.